Yipinhong Pharmaceutical Co Ltd Class A Net Asset Quality Index
Yipinhong Pharmaceutical Co Ltd Class A net asset quality index. Yipinhong Pharmaceutical Co Ltd Class A (300723) has a Net Asset Quality Index of 41.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.49 Billion minus total liabilities of CN¥2.61 Billion yields net assets of CN¥1.88 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how high is Yipinhong Pharmaceutical Co Ltd Class A's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
Net asset quality index of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. This chart shows how Yipinhong Pharmaceutical Co Ltd Class A's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 41.9%, representing net assets of CN¥1.88 Billion against total assets of CN¥4.49 Billion CNY. See 300723 net asset value for net asset value and shareholders' equity analysis.
Yipinhong Pharmaceutical Co Ltd Class A Net Asset Quality Index by Year (2013–2025)
Yipinhong Pharmaceutical Co Ltd Class A net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Yipinhong Pharmaceutical Co Ltd Class A worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.8% | CN¥1.41 Billion | CN¥4.04 Billion | CN¥2.64 Billion | ▼ -9.2 pp |
| 2024 | 44.0% | CN¥1.94 Billion | CN¥4.40 Billion | CN¥2.47 Billion | ▼ -15.0 pp |
| 2023 | 59.0% | CN¥2.60 Billion | CN¥4.41 Billion | CN¥1.81 Billion | ▲ +6.1 pp |
| 2022 | 52.8% | CN¥2.17 Billion | CN¥4.10 Billion | CN¥1.93 Billion | ▼ -1.6 pp |
| 2021 | 54.5% | CN¥2.02 Billion | CN¥3.70 Billion | CN¥1.69 Billion | ▼ -15.2 pp |
| 2020 | 69.7% | CN¥1.50 Billion | CN¥2.15 Billion | CN¥650.14 Million | ▼ -5.0 pp |
| 2019 | 74.7% | CN¥1.34 Billion | CN¥1.79 Billion | CN¥454.20 Million | ▲ +1.7 pp |
| 2018 | 73.0% | CN¥1.30 Billion | CN¥1.78 Billion | CN¥481.67 Million | ▼ -1.8 pp |
| 2017 | 74.8% | CN¥1.11 Billion | CN¥1.48 Billion | CN¥373.45 Million | ▲ +30.1 pp |
| 2016 | 44.7% | CN¥336.50 Million | CN¥752.32 Million | CN¥415.82 Million | ▲ +12.9 pp |
| 2015 | 31.8% | CN¥200.66 Million | CN¥630.56 Million | CN¥429.90 Million | ▲ +14.4 pp |
| 2014 | 17.4% | CN¥127.52 Million | CN¥733.80 Million | CN¥606.28 Million | ▼ -27.8 pp |
| 2013 | 45.1% | CN¥185.61 Million | CN¥411.27 Million | CN¥225.66 Million | — |